c - Search

Clinical Trials

• C-PHONE Study
  ClinicalTrials.gov Identifier: NCT00211601 - Active, not recruiting
  Chemotherapy Induced Nausea and Vomiting
  
• C-Reactive Protein (CRP) in Obese Diabetic Women
  ClinicalTrials.gov Identifier: NCT00262548 - Completed
  Diabetes Mellitus, Type 2
  
• C-Reactive Protein (CRP)-Guided Management Algorithm for Adults with Acute Cough
  ClinicalTrials.gov Identifier: NCT00221351 - Active, not recruiting
  Cough
  
• C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
  ClinicalTrials.gov Identifier: NCT00179868 - Recruiting
  Cancer; Leukemia
  
• C-Spine Movement - Shikani Optical Scope vs Macintosh Laryngoscope for Patients With Cervical Spine Injury
  ClinicalTrials.gov Identifier: NCT00310999 - Completed
  Wounds and Injuries
  
• C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00402545 - Recruiting
  Head and Neck Neoplasms
  
• C.A.T.C.H.-I.T.Competent Adulthood Transition with Cognitive, Humanistic and Interpersonal Teaching
  ClinicalTrials.gov Identifier: NCT00152529 - Terminated
  Depression
  
• C1 Esterase Inhibitor (Human) for the Treatment and Prevention of Acute Hereditary Angioedema (HAE) Attacks
  ClinicalTrials.gov Identifier: NCT00289211 - Completed
  Hereditary Angioedema
  
• C1 Esterase Inhibitor in HAE (Extension Study)
  ClinicalTrials.gov Identifier: NCT00292981 - Active, not recruiting
  Hereditary Angioedema
  
• C2P - Phase III (With Venues)
  ClinicalTrials.gov Identifier: NCT00271908 - Recruiting
  HIV
  
• C2P – Phase III:MPowerment and Community Promise
  ClinicalTrials.gov Identifier: NCT00381784 - Recruiting
  HIV Infections
  
• C2P Mobilization Intervention (Pilot)
  ClinicalTrials.gov Identifier: NCT00393575 - Recruiting
  HIV Infections
  
• CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
  ovarian epithelial cancer
  
• CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
  ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• CA-125 in Screening Patients at High Risk for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00080639 - Active, not recruiting
  ovarian epithelial cancer
  
• Cabergoline Reduces OHSS
  ClinicalTrials.gov Identifier: NCT00440258 - Completed
  Ovarian Hyperstimulation Syndrome
  
• CABG Off or On Pump Revascularization Study
  ClinicalTrials.gov Identifier: NCT00463294 - Recruiting
  Coronary Artery Bypass
  
• CABG Without the Use of CPB
  ClinicalTrials.gov Identifier: NCT00202332 - Active, not recruiting
  Coronary Artery Bypass
  
• CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00227344 - Recruiting
  Atrial Fibrillation
  
• Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00579371 - Enrolling by invitation
  Islets of Langerhans Transplantation; Diabetes Mellitus, Type 1
  
• Caduet in an Untreated Subject Population.
  ClinicalTrials.gov Identifier: NCT00332761 - Completed
  Hypertension; Dyslipidemia
  
• Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
  ClinicalTrials.gov Identifier: NCT00407537 - Recruiting
  Hypertension
  
• Caelyx Adjuvant in Elderly Breast Cancer
  ClinicalTrials.gov Identifier: NCT00284336 - Completed
  Breast Cancer; Elderly
  
• Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
  ClinicalTrials.gov Identifier: NCT00563953 - Recruiting
  Breast Cancer
  
• Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00170573 - Active, not recruiting
  Ovarian Cancer
  
• Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
  ClinicalTrials.gov Identifier: NCT00189553 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer
  
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258960 - Recruiting
  Breast Cancer
  
• Caesarean and Corticotherapy
  ClinicalTrials.gov Identifier: NCT00446953 - Recruiting
  Neonatal Distress
  
• CAFE Comparison of Atypicals in First Episode
  ClinicalTrials.gov Identifier: NCT00034892 - Completed
  Schizophrenia; Psychotic Disorders; Mental Health; Mental Disorders
  
• CAFE Study - Cancer Patient Fracture Evaluation
  ClinicalTrials.gov Identifier: NCT00211237 - Recruiting
  Cancer; Spinal Fractures
  
• Cafeteria-Based Study of Weight Gain Prevention
  ClinicalTrials.gov Identifier: NCT00142662 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Caffeine and Intermittent Claudication
  ClinicalTrials.gov Identifier: NCT00388128 - Recruiting
  Intermittent Claudication
  
• Caffeine for Apnea of Prematurity (CAP)
  ClinicalTrials.gov Identifier: NCT00182312 - Active, not recruiting
  Apnea of Prematurity
  
• Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00459420 - Recruiting
  Parkinson's Disease; Excessive Daytime Somnolence
  
• Caffeine in the Prevention of Post-Operative Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00130026 - Completed
  POSTOP NAUSEA VOMITING
  
• Caffeinol Hypothermia Protocol
  ClinicalTrials.gov Identifier: NCT00299416 - Recruiting
  Acute Ischemic Stroke
  
• CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00330746 - Active, not recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Calcifidol Therapy in Men with Cancer
  ClinicalTrials.gov Identifier: NCT00018538 - Completed
  Prostate Cancer
  
• Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00305396 - Completed
  Kidney Transplantation
  
• Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
  ClinicalTrials.gov Identifier: NCT00541814 - Recruiting
  Chronic Allograft Nephropathy
  
• Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk
  ClinicalTrials.gov Identifier: NCT00138970 - Completed
  Renal transplant recipients
  
• Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
  ClinicalTrials.gov Identifier: NCT00358839 - Completed
  Familial Hemiplegic Migraine
  
• Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00084864 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
  Myelodysplastic Syndromes
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00524589 - Recruiting
  Prostate Cancer
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00238199 - Active, not recruiting
  Pancreatic Cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00301067 - Suspended
  Intraocular Melanoma; Melanoma (Skin)
  
• Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Calcitriol in Preventing Prostate Cancer in Patients with Prostatic Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00118066 - Recruiting
  Prostate Cancer; Precancerous Condition
  
• Calcitriol in the Treatment of IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00319761 - Active, not recruiting
  IGA Nephropathy
  
• Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004043 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
  ClinicalTrials.gov Identifier: NCT00482157 - Not yet recruiting
  Prostatic Neoplasms
  
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
  Brain Tumor; Genetic Condition; Solid Tumor
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009802 - Completed
  unspecified adult solid tumor, protocol specific
  
• Calcitriol, Cisplatin, and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00470431 - Recruiting
  Lung Cancer
  
• Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00238225 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00536991 - Recruiting
  Prostate Cancer
  
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182741 - Active, not recruiting
  Prostate Cancer
  
• Calcium Absorption and Retention From Marine Products
  ClinicalTrials.gov Identifier: NCT00393289 - Active, not recruiting
  Calcium Metabolism
  
• Calcium and Bone Mass in Young Females
  ClinicalTrials.gov Identifier: NCT00000402 - Completed
  Osteoporosis
  
• Calcium and Vitamin D Malnutrition in Elderly Women
  ClinicalTrials.gov Identifier: NCT00352170 - Active, not recruiting
  Osteoporosis; Secondary Hyperparathyroidism
  
• Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits
  ClinicalTrials.gov Identifier: NCT00476346 - Completed
  Stress Fracture
  
• Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging
  ClinicalTrials.gov Identifier: NCT00251615 - Recruiting
  Atherosclerosis
  
• Calcium Current in Human Heart Cells
  ClinicalTrials.gov Identifier: NCT00243776 - Recruiting
  Congenital Heart Disease; Tetralogy of Fallot
  
• Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00205036 - Recruiting
  Healthy
  
• Calcium for Pre-Eclampsia Prevention (CPEP)
  ClinicalTrials.gov Identifier: NCT00000534 - Completed
  Cardiovascular Diseases; Eclampsia; Heart Diseases; HELLP Syndrome; Hypertension; Pre-Eclampsia; Pregnancy Toxemias; Vascular Diseases
  
• Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00316914 - Active, not recruiting
  Colorectal Cancer; Neurotoxicity
  
• Calcium Intake, Metabolism, and Gestational Blood Pressure
  ClinicalTrials.gov Identifier: NCT00005206 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
  ClinicalTrials.gov Identifier: NCT00386672 - Active, not recruiting
  Obesity; Overweight
  
• Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00000429 - Completed
  Juvenile Rheumatoid Arthritis
  
• Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
  Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children Aged 1-6 Years in Low Socio-Economic Urban Area of East Jakarta
  ClinicalTrials.gov Identifier: NCT00512824 - Recruiting
  Healthy; Diarrhea
  
• Calcium, Vitamin D, and Colon Cancer Risk Biomarkers
  ClinicalTrials.gov Identifier: NCT00208793 - Active, not recruiting
  Colonic Polyps; Adenomatous Polyps
  
• Calcium/Vitamin D, Biomarkers,& Colon Polyp Prevention
  ClinicalTrials.gov Identifier: NCT00399607 - Recruiting
  Adenomatous Colon Polyps
  
• CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099151 - Completed
  Aging; Cardiovascular Disease; Diabetes Mellitus
  
• CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099099 - Completed
  Aging
  
• CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099138 - Completed
  Aging
  
• CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00427193 - Recruiting
  Aging
  
• Calibration of Non-Invasive Non-Ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00546091 - Recruiting
  Healthy Volunteers Only
  
• Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods
  ClinicalTrials.gov Identifier: NCT00339443 - Active, not recruiting
  Calibration
  
• California WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153400 - Not yet recruiting
  CVD risk
  
• CALM-AD
  ClinicalTrials.gov Identifier: NCT00142324 - Active, not recruiting
  Alzheimer''s Disease
  
• Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development
  ClinicalTrials.gov Identifier: NCT00317551 - Completed
  Myopia
  
• Caminemos! Trial to Increase Walking Among Sedentary Older Latinos
  ClinicalTrials.gov Identifier: NCT00183014 - Recruiting
  Aging; Sedentary Lifestyle
  
• Campath in Chronic GVHD
  ClinicalTrials.gov Identifier: NCT00495755 - Recruiting
  Chronic Graft-vs.-Host Disease
  
• Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation
  ClinicalTrials.gov Identifier: NCT00579592 - Active, not recruiting
  Acute Rejection; Renal Transplantation
  
• Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00038883 - Terminated
  Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell
  
• Campath-1H and EPOCH to Treat non-Hodgkin's T- and NK-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00069238 - Recruiting
  Lymphoma
  
• Campath-1H for Treating Adult T-Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00061048 - Recruiting
  Acute T-Cell Leukemia-Lymphoma
  
• Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00214201 - Active, not recruiting
  Primary Renal Transplant
  
• Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00167661 - Recruiting
  Renal Transplantation
  
• Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
  ClinicalTrials.gov Identifier: NCT00071396 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
  ClinicalTrials.gov Identifier: NCT00251888 - Completed
  Cervix Cancer.
  
• Campus Health Intervention Projects UBC Site
  ClinicalTrials.gov Identifier: NCT00278733 - Completed
  High Risk Drinking
  
• Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
  ClinicalTrials.gov Identifier: NCT00434798 - Recruiting
  Campylobacter Infections
  
• Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?
  ClinicalTrials.gov Identifier: NCT00163904 - Recruiting
  Heart Failure
  
• Can a Novel Treatment Using "Mandometer®" Technology Improve Weight Loss in a Childhood Obesity Clinic?
  ClinicalTrials.gov Identifier: NCT00407420 - Completed
  Childhood Obesity
  
• Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity?
  ClinicalTrials.gov Identifier: NCT00107692 - Active, not recruiting
  Obesity
  
• Can a Very High Result From a Screening Test for Celiac Disease Be Used to Diagnose Celiac Disease?
  ClinicalTrials.gov Identifier: NCT00175760 - Recruiting
  Celiac Disease
  
• Can Acupuncture Be Used as Preparation for Induction of Labour
  ClinicalTrials.gov Identifier: NCT00245752 - Recruiting
  Pregnancy Overdue - Week 41+6
  
• Can Additional Drug Therapy Accelerate Response Time to Antidepressants
  ClinicalTrials.gov Identifier: NCT00221494 - Active, not recruiting
  Depression
  
• Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? a Multi-Center Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00120978 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
  ClinicalTrials.gov Identifier: NCT00261625 - Not yet recruiting
  End-Stage Renal Disease; Peritoneal Dialysis; Osteoporosis
  
• Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery
  ClinicalTrials.gov Identifier: NCT00357851 - Recruiting
  Pancreatitis
  
• Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
  ClinicalTrials.gov Identifier: NCT00468494 - Recruiting
  General Anesthesia; Hyperglycemia
  
• Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?
  ClinicalTrials.gov Identifier: NCT00251810 - Active, not recruiting
  General Anaesthesia
  
• Can CT Enteroclysis Predict the Outcome of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00572780 - Active, not recruiting
  Crohn's Disease
  
• Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
  ClinicalTrials.gov Identifier: NCT00431925 - Not yet recruiting
  Oral Mucositis; Xerostomia; Weight Loss; Head and Neck Cancer
  
• Can Education for South Asians with Asthma and Their Clinicians Reduce Unscheduled Care? A Randomised Trial
  ClinicalTrials.gov Identifier: NCT00214669 - Recruiting
  Asthma
  
• Can Erythopoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
  ClinicalTrials.gov Identifier: NCT00265486 - Recruiting
  Healthy
  
• Can Group Visits Improve Outcomes of Veterans With Diabetes
  ClinicalTrials.gov Identifier: NCT00286741 - Recruiting
  Diabetes; Hypertension
  
• Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?
  ClinicalTrials.gov Identifier: NCT00340951 - Completed
  Lung Transplantation
  
• Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
  ClinicalTrials.gov Identifier: NCT00172302 - Not yet recruiting
  Kidney Failure, Chronic
  
• Can MRSA Screening Reduce ICU Infections?
  ClinicalTrials.gov Identifier: NCT00428259 - Not yet recruiting
  Cross Infection
  
• Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?
  ClinicalTrials.gov Identifier: NCT00164970 - Recruiting
  Dementia
  
• Can parathyroid hormone injections reverse glucocorticoid-induced osteoporosis
  ClinicalTrials.gov Identifier: NCT00004993 - Completed
  Osteoporosis
  
• Can Parental Activation Over the Internet Improve Pediatric Preventive Care?
  ClinicalTrials.gov Identifier: NCT00101855 - Active, not recruiting
  well child preventive care
  
• Can Quantitative Ultrasound Be Used for the Evaluation of Bone Health in Adolescents and Adults with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221572 - Recruiting
  Cystic Fibrosis
  
• Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
  ClinicalTrials.gov Identifier: NCT00279552 - Completed
  Vitamin B12 Deficiency
  
• Can Resistance Enhance Selection of Treatment? (CREST)
  ClinicalTrials.gov Identifier: NCT00262717 - Completed
  HIV Infection
  
• Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?
  ClinicalTrials.gov Identifier: NCT00214708 - Active, not recruiting
  Tuberculosis
  
• Can Structured Education Promote Physical Activity in Those Identified With an Increased Risk of Developing Diabetes
  ClinicalTrials.gov Identifier: NCT00566319 - Active, not recruiting
  Prediabetic State
  
• Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
  ClinicalTrials.gov Identifier: NCT00215631 - Terminated
  Prostate Cancer; Erectile Dysfunction
  
• Can Targeted Elimination of B-Cell Depletion Therapy and/or Combination Therapy on SLE
  ClinicalTrials.gov Identifier: NCT00556192 - Recruiting
  Systemic Lupus Erythematosus
  
• Can Thought Field Therapy (TFT) Be Helpful for Patients With an Anxiety Disorder?
  ClinicalTrials.gov Identifier: NCT00202709 - Completed
  Agoraphobia; Social Phobia
  
• Can Ultrasound be Used to Verify CVC Position and to Exclude Pneumothorax?
  ClinicalTrials.gov Identifier: NCT00388375 - Recruiting
  Catheterization, Central Venous
  
• Can Vignettes Be Used to Improve Practice & Outcome
  ClinicalTrials.gov Identifier: NCT00122148 - Terminated
  
  
• Can We Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation
  ClinicalTrials.gov Identifier: NCT00129701 - Completed
  Asthma; COPD; Sleep Apnea Syndromes; Interstitial Lung Disease; Bronchiectasis
  
• Canactfast: Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
  ClinicalTrials.gov Identifier: NCT00150371 - Completed
  Hypercholesterolemia (D006937)
  
• Canadian Aesthetic Experience With Sculptra Therapy
  ClinicalTrials.gov Identifier: NCT00447551 - Active, not recruiting
  Skin Aging
  
• Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.
  ClinicalTrials.gov Identifier: NCT00332332 - Recruiting
  Psoriasis
  
• Canadian C-Spine Rule Study
  ClinicalTrials.gov Identifier: NCT00290875 - Recruiting
  Cspine Injury
  
• Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study
  ClinicalTrials.gov Identifier: NCT00455104 - Recruiting
  Fabry Disease
  
• Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study
  ClinicalTrials.gov Identifier: NCT00552136 - Recruiting
  Ankle Arthritis
  
• Canadian Pegvisomant Compassionate Study In Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00151437 - Completed
  Acromegaly
  
• Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)
  ClinicalTrials.gov Identifier: NCT00182546 - Terminated
  Suspected Pulmonary Embolism; Deep Venous Thrombosis
  
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
  ClinicalTrials.gov Identifier: NCT00233532 - Active, not recruiting
  Hypertension
  
• Canadian Trial of Dietary Carbohydrates in Diabetes
  ClinicalTrials.gov Identifier: NCT00223574 - Completed
  Type 2 Diabetes
  
• Canalith Repositioning Procedure for BPPV in Primary Care
  ClinicalTrials.gov Identifier: NCT00182273 - Completed
  Benign Paroxysmal Positional Vertigo
  
• CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
  ClinicalTrials.gov Identifier: NCT00219973 - Recruiting
  Cancer; Venous Thromboembolism
  
• Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
  ClinicalTrials.gov Identifier: NCT00236002 - Terminated
  Osteoporosis
  
• Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
  ClinicalTrials.gov Identifier: NCT00322647 - Completed
  Cancer
  
• Cancer Detection in Pancreatic Cysts
  ClinicalTrials.gov Identifier: NCT00222898 - Completed
  Pancreatic Cyst; Pancreatic Pseudocyst; Pancreatic Neoplasm
  
• Cancer Dietary Objectives Study
  ClinicalTrials.gov Identifier: NCT00561977 - Recruiting
  Cancer; Heart Disease
  
• Cancer Genetics CD-ROM for Hispanics
  ClinicalTrials.gov Identifier: NCT00525980 - Recruiting
  Breast Cancer
  
• Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-Antigen-Positive Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00455572 - Recruiting
  Tumor-Antigen-Positive Non-Small-Cell Lung Cancer
  
• Cancer in Inherited Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00027274 - Recruiting
  Fanconi's Anemia; Anemia, Diamond-Blackfan; Dyskeratosis Congenital; Thrombocytopenia; Neutropenia
  
• Cancer of the Pancreas Screening Study (CAPS 3)
  ClinicalTrials.gov Identifier: NCT00438906 - Recruiting
  Pancreatic Neoplasm; Peutz-Jeghers Syndrome
  
• Cancer Pain
  ClinicalTrials.gov Identifier: NCT00046709 - Terminated
  Neoplasms
  
• Cancer Patients' Medication Knowledge in the Emergency Center
  ClinicalTrials.gov Identifier: NCT00385476 - Recruiting
  Advanced Cancer
  
• Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial
  ClinicalTrials.gov Identifier: NCT00509444 - Recruiting
  Breast Cancer; Colon Cancer; Rectum Cancer; Cervix Cancer; Prostate Cancer; Lung Cancer
  
• Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
  ClinicalTrials.gov Identifier: NCT00453661 - Recruiting
  Breast Cancer; Cervical Cancer; Prostate Cancer; Colorectal Cancer; Lung Cancer
  
• Cancer Related Fatigue in Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00261534 - Active, not recruiting
  Cancer; Fatigue
  
• Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
  ClinicalTrials.gov Identifier: NCT00046189 - Recruiting
  Xeroderma Pigmentosum
  
• Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
  ClinicalTrials.gov Identifier: NCT00049621 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Cancer Risk in X-Ray Technologists: Second Survey
  ClinicalTrials.gov Identifier: NCT00410475 - Active, not recruiting
  Neoplasm
  
• Cancer Treatment Followed by Surgery for Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00313690 - Recruiting
  Lung Cancer
  
• Cancer Vaccine for Lymphoma following Chemotherapy
  ClinicalTrials.gov Identifier: NCT00001945 - No longer recruiting
  B Cell Lymphoma; Follicular Lymphoma
  
• Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00409188 - Recruiting
  Non-Small Cell Lung Cancer
  
• Cancer-Preventing Qualities of Broccoli Sprouts Tea
  ClinicalTrials.gov Identifier: NCT00090350 - No longer recruiting
  Hepatocellular Carcinoma
  
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00125463 - Active, not recruiting
  Hypertension; Cardiovascular Diseases
  
• Candesartan Effectiveness Study in Pro-BNP
  ClinicalTrials.gov Identifier: NCT00348686 - Active, not recruiting
  Hypertension; Left Ventricular Hypertrophy
  
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
  ClinicalTrials.gov Identifier: NCT00139386 - Recruiting
  Hypertension; Coronary Artery Disease; Coronary Angioplasty
  
• Candesartan in the Prevention of Relapsing Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00130975 - Completed
  Atrial Fibrillation
  
• Candidate HIV Vaccine
  ClinicalTrials.gov Identifier: NCT00089531 - Active, not recruiting
  HIV Infections
  
• CANDIS - Targeted Treatment for Cannabis Disorders
  ClinicalTrials.gov Identifier: NCT00252980 - Active, not recruiting
  Cannabis Use Disorder
  
• Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
  ClinicalTrials.gov Identifier: NCT00385138 - Recruiting
  Atherosclerosis
  
• Cannabinoids in Bipolar Affective Disorder
  ClinicalTrials.gov Identifier: NCT00397605 - Recruiting
  Bipolar Affective Disorder
  
• Cannabis Cigarettes Used for Doping: THC Urine Detection
  ClinicalTrials.gov Identifier: NCT00534716 - Recruiting
  Healthy
  
• Cannabis for Spasticity in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00260741 - Terminated
  Multiple Sclerosis
  
• CAP
  ClinicalTrials.gov Identifier: NCT00172172 - Active, not recruiting
  Osteoporosis
  
• Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00254137 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Capadenoson in Angina Pectoris
  ClinicalTrials.gov Identifier: NCT00518921 - Not yet recruiting
  Chronic Stable Angina
  
• Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00496366 - Recruiting
  Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; HER2/Neu-Positive Breast Cancer
  
• Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
  ClinicalTrials.gov Identifier: NCT00216424 - Terminated
  Colorectal Cancer
  
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00216086 - Recruiting
  Rectal Cancer
  
• Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291486 - Active, not recruiting
  Colorectal Neoplasms
  
• Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00257348 - Completed
  Cervical Cancer
  
• Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00258284 - Active, not recruiting
  Prostate Cancer
  
• Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00290693 - Recruiting
  Pancreatic Cancer
  
• Capecitabine and Gemcitabine in Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00159445 - Recruiting
  Colorectal Cancer; Colon Cancer
  
• Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00042965 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00022698 - Completed
  Colon Cancer; Rectal Cancer
  
• Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
  ClinicalTrials.gov Identifier: NCT00354887 - Active, not recruiting
  Gastrointestinal Cancer
  
• Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00104689 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004187 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00101075 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00354224 - Recruiting
  Gastric Cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00216021 - Completed
  Metastatic Breast Cancer
  
• Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00427713 - Recruiting
  Colorectal Cancer
  
• Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00397761 - Recruiting
  Breast Cancer
  
• Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00031876 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
  ClinicalTrials.gov Identifier: NCT00227656 - Completed
  Brain and Central Nervous System Tumors; Breast Cancer
  
• Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00176735 - Terminated
  Pancreatic Cancer
  
• Capecitabine and Radiation Therapy in Treating Patients with Locally Advanced Cervical Cancer Or Other Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00118300 - Completed
  Endocrine Cancer; female reproductive cancer
  
• Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery
  ClinicalTrials.gov Identifier: NCT00562718 - Recruiting
  Breast Cancer
  
• Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00357253 - Recruiting
  Brain and Central Nervous System Tumors
  
• Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00165217 - Completed
  Colorectal Adenocarcinoma
  
• Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00077363 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
  ClinicalTrials.gov Identifier: NCT00003902 - Active, not recruiting
  stage IV breast cancer
  
• Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00347438 - Recruiting
  Breast Cancer
  
• Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
  ClinicalTrials.gov Identifier: NCT00303927 - Recruiting
  Pancreatic Cancer
  
• Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00270491 - Recruiting
  Breast Cancer; Metastatic Disease
  
• Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00010023 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
  
• Capecitabine Compared With Fluorouracil Plus Leucovorin in Treating Patients Who Have Undergone Surgery for Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00009737 - Active, not recruiting
  stage III colon cancer
  
• Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00049660 - Active, not recruiting
  stage IV breast cancer
  
• Capecitabine in Combination with Oxaliplatin (XELOX) vs. Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma
  ClinicalTrials.gov Identifier: NCT00069121 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049335 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Capecitabine in Treating Patients Who Have Undergone Previous Surgery, Radiation Therapy, and/or Chemotherapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00258310 - Active, not recruiting
  Head and Neck Cancer
  
• Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095641 - Not yet recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00016926 - Completed
  stage III cervical cancer; recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma
  
• Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
  ClinicalTrials.gov Identifier: NCT00095901 - Active, not recruiting
  recurrent squamous cell carcinoma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Capecitabine in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00004183 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; sarcomatous mesothelioma; ...
  
• Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00274768 - Recruiting
  Breast Cancer
  
• Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00039442 - Active, not recruiting
  recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma
  
• Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004012 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026442 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Capecitabine in Treating Women With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00006812 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Capecitabine in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148720 - Active, not recruiting
  Invasive Breast Carcinoma; Primary Invasive Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage III Breast Cancer
  
• Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00215501 - Active, not recruiting
  Solid Tumor
  
• Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00363584 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
  
• Capecitabine Plus GTI-2040 in Treating Patients With Advanced or Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00084331 - Recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
  ClinicalTrials.gov Identifier: NCT00561522 - Recruiting
  Recurrence; Metastasis; Hepatocellular Carcinoma; Surgery
  
• Capecitabine vs. S-1 in Elderly AGC: Randomized Phase II Trial
  ClinicalTrials.gov Identifier: NCT00278863 - Completed
  Gastric Cancer
  
• Capecitabine(Xeloda) With Or Without Lapatinib(GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00078572 - Active, not recruiting
  Advanced Breast Cancer; Metastatic breast cancer
  
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
  
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00201734 - Recruiting
  Tumors; Unknown Primary Tumors; Adenocarcinoma
  
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00290615 - Recruiting
  Colorectal Cancer
  
• Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
  ClinicalTrials.gov Identifier: NCT00320749 - Recruiting
  Pancreatic Cancer
  
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00486356 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00496587 - Recruiting
  Renal Cell Carcinoma
  
• Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00544063 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00216073 - Terminated
  Metastatic Breast Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients Who Are Undergoing Surgery for Liver Metastases Due to Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00118105 - Completed
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; liver metastases
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00416494 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Previously Untreated, Unresectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00450346 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00087334 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00114231 - Recruiting
  adenocarcinoma of the rectum; stage I rectal cancer
  
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00093379 - Recruiting
  stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer; squamous cell carcinoma of the anus
  
• Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients with Biliary Tract and Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00142480 - Recruiting
  Biliary tract adenocarcinoma; Gallbladder adenocarcinoma
  
• Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006108 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093808 - Recruiting
  recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
  
• Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00353457 - Recruiting
  Rectal Cancer
  
• Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotnib Followed of Capecitabine
  ClinicalTrials.gov Identifier: NCT00440167 - Recruiting
  Advanced; Pancreatic Cancer
  
• Capillary and Venous Blood Count Parameters
  ClinicalTrials.gov Identifier: NCT00390988 - Completed
  Hematological Diseases; Healthy Volunteers; Adult
  
• CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation
  ClinicalTrials.gov Identifier: NCT00271076 - Completed
  Carotid Artery Disease
  
• CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
  ClinicalTrials.gov Identifier: NCT00526643 - Not yet recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Capravirine (AG1549) in Combination with Viracept and Two NRTIs in HIV infected Patients Who Failed an Initial NNRTI Containing Regimen
  ClinicalTrials.gov Identifier: NCT00051844 - Completed
  Human Immunodeficiency Virus
  
• Capravirine to Treat Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00006519 - Completed
  HIV Infection
  
• Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003610 - Completed
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Capsaicin to Control Pain Following Third Molar Extraction
  ClinicalTrials.gov Identifier: NCT00008476 - Completed
  Facial Pain
  
• Capsaicin to Control Pain Following Third Molar Extraction
  ClinicalTrials.gov Identifier: NCT00088686 - Completed
  Healthy; Tooth Extraction
  
• Capsaicin-Evoked Pain in Patients With CRPS
  ClinicalTrials.gov Identifier: NCT00468390 - Recruiting
  CRPS (Complex Regional Pain Syndromes)
  
• Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy
  ClinicalTrials.gov Identifier: NCT00530231 - Recruiting
  Capsule Endoscopy
  
• Capsule Endoscopy in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00333957 - Recruiting
  Cystic Fibrosis
  
• Capsule Endoscopy in Obscure GI Bleeding
  ClinicalTrials.gov Identifier: NCT00203619 - Active, not recruiting
  Obscure Gastrointestinal Bleeding
  
• Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt GIB of Obscure Origin
  ClinicalTrials.gov Identifier: NCT00153686 - Recruiting
  Gastrointestinal Hemorrhage
  
• Capsule Endoscopy vs. Push Enteroscopy in Occult Gastrointestinal Bleeding OGIB
  ClinicalTrials.gov Identifier: NCT00224627 - Completed
  Occult Gastrointestinal Bleeding
  
• CAPTAIN:CNV Assessment by Pattern Electroretinography
  ClinicalTrials.gov Identifier: NCT00500344 - Recruiting
  Age-Related Macular Degeneration
  
• Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00004230 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
  ClinicalTrials.gov Identifier: NCT00077064 - Active, not recruiting
  limited stage small cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; Radiation Fibrosis
  
• CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
  ClinicalTrials.gov Identifier: NCT00275769 - Completed
  Arrhythmia; Bradycardia
  
• CAPTURE 2 Post-Marketing Registry
  ClinicalTrials.gov Identifier: NCT00302237 - Recruiting
  Carotid Artery Disease
  
• Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
  ClinicalTrials.gov Identifier: NCT00351676 - Completed
  Heart Failure, Congestive; Pulmonary Disease, Chronic Obstructive; Pneumonia; Diabetes Mellitus, Type 2; Coronary Arteriosclerosis
  
• Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
  ClinicalTrials.gov Identifier: NCT00357864 - Completed
  Headache
  
• Carbachols Headacheinducing Effect and Changes in Cerebral Blood Flow in Migraine Patients
  ClinicalTrials.gov Identifier: NCT00564408 - Recruiting
  Headache
  
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00203567 - Recruiting
  Bipolar Depression
  
• Carbamazepine Treatment for Cocaine Dependence - 5
  ClinicalTrials.gov Identifier: NCT00000191 - Completed
  Cocaine-Related Disorders
  
• Carbamazepine Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00000242 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Carbetocin Versus Syntometrine for the Third Stage of Labour
  ClinicalTrials.gov Identifier: NCT00499005 - Recruiting
  Postpartum Haemorrhage
  
• Carbon Monoxide to Prevent Lung Inflammation
  ClinicalTrials.gov Identifier: NCT00094406 - Recruiting
  
  
• Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00392938 - Recruiting
  Metastatic Cancer; Prostate Cancer
  
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00456859 - Completed
  Kidney Failure, Chronic
  
• Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00404235 - Recruiting
  Melanoma (Skin)
  
• Carboplatin and Docetaxel After Surgery in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00280735 - Active, not recruiting
  Lung Cancer
  
• Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00061919 - Active, not recruiting
  extensive stage small cell lung cancer; limited stage small cell lung cancer
  
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00070486 - Active, not recruiting
  stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00470249 - Recruiting
  Breast Cancer
  
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00400803 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024284 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00553462 - Not yet recruiting
  Lung Cancer
  
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00520000 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
  ClinicalTrials.gov Identifier: NCT00322881 - Recruiting
  Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer; Mesodermal Tumors
  
• Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005059 - Completed
  stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; psychosocial effects/treatment
  
• Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00003206 - Completed
  recurrent nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00565851 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00483782 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00262847 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Cediranib in Treating Women With Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00544973 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00052468 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00017407 - Completed
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00110019 - Recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00481078 - Recruiting
  Lung Cancer
  
• Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00230542 - Recruiting
  Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
  
• Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
  ClinicalTrials.gov Identifier: NCT00362817 - Recruiting
  Brain Tumor
  
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Carboplatin Combined with Paclitaxel in Treating Patients With Advanced Thymoma
  ClinicalTrials.gov Identifier: NCT00010257 - Recruiting
  invasive thymoma and thymic carcinoma; recurrent thymoma and thymic carcinoma
  
• Carboplatin in Patients With Progressive Gliomas
  ClinicalTrials.gov Identifier: NCT00002749 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood visual pathway glioma; recurrent childhood cerebral astrocytoma; ...
  
• Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00098878 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00321633 - Recruiting
  Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2)
  
• Carboplatin plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00097214 - Completed
  Non-small cell lung cancer
  
• Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00085358 - Recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00010036 - Active, not recruiting
  adult glioblastoma multiforme
  
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003998 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
  
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003644 - Active, not recruiting
  ovarian epithelial cancer
  
• Carboplatin Plus Taxotere in Anaplastic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00514540 - Recruiting
  Prostate Cancer
  
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003255 - Completed
  secondary acute myeloid leukemia; recurrent adult acute myeloid leukemia
  
• Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003015 - Active, not recruiting
  untreated childhood visual pathway glioma; low-grade childhood cerebral astrocytoma; untreated childhood cerebellar astrocytoma; ...
  
• Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002794 - Active, not recruiting
  intraocular retinoblastoma
  
• Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004096 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Carboplatin Taxol Avastin in OVCA
  ClinicalTrials.gov Identifier: NCT00129727 - Recruiting
  Ovarian Cancer
  
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00551733 - Recruiting
  Lung Cancer
  
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006453 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004876 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00114153 - Completed
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the lip and oral cavity; ...
  
• Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00075387 - Recruiting
  adult anaplastic astrocytoma; adult anaplastic ependymoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; ...
  
• Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00258362 - Active, not recruiting
  Endometrial Cancer
  
• Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00002943 - Completed
  adult solid tumor; extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer
  
• Carboplatin, Gemcitabine, and Thalidomide in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00281827 - Recruiting
  Lung Cancer
  
• Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00449020 - Completed
  Lung Cancer
  
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00088556 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
  ClinicalTrials.gov Identifier: NCT00352300 - Recruiting
  Fallopian Tube Cancer; Infection; Neutropenia; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003387 - Active, not recruiting
  Squamous Cell Lung Cancer; stage III non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004859 - Active, not recruiting
  Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; ...
  
• Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00331422 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00526890 - Recruiting
  Lung Cancer
  
• Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00234052 - Recruiting
  Lung Cancer
  
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00006263 - Active, not recruiting
  adult brain stem glioma; adult glioblastoma multiforme; high-grade childhood cerebral astrocytoma; adult anaplastic astrocytoma; ...
  
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00077207 - Active, not recruiting
  untreated childhood cerebellar astrocytoma; untreated childhood visual pathway and hypothalamic glioma; childhood spinal cord tumors; ...
  
• Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00003249 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
  ClinicalTrials.gov Identifier: NCT00019019 - Completed
  Brain and Central Nervous System Tumors; Breast Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Melanoma (Skin); Ovarian Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005045 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00006486 - Completed
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00019461 - Completed
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003869 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Carboxyamidotriazole Plus Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00004146 - Active, not recruiting
  adult glioblastoma multiforme
  
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
  ClinicalTrials.gov Identifier: NCT00018967 - Completed
  Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Carcinoembryonic Antigen-Loaded Dendritic Cells in Advanced Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00228189 - Recruiting
  Colorectal Cancer; Liver Metastases
  
• Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00450281 - Recruiting
  Lung Cancer
  
• Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
  ClinicalTrials.gov Identifier: NCT00384540 - Recruiting
  Allograft Vasculopathy
  
• Cardiac and Renal Disease Study (CARDS)
  ClinicalTrials.gov Identifier: NCT00049907 - Completed
  Coronary Disease; Cardiovascular Diseases; Cerebrovascular Accident; Heart Failure; Heart Diseases; Peripheral Vascular Diseases; Diabetes Mellitus; ...
  
• Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
  ClinicalTrials.gov Identifier: NCT00461240 - Not yet recruiting
  Acromegaly; Growth Hormone Deficiency
  
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
  ClinicalTrials.gov Identifier: NCT00000464 - Completed
  Arrhythmia; Cardiovascular Diseases; Heart Arrest; Heart Diseases; Myocardial Infarction; Ventricular Fibrillation
  
• Cardiac Arrest Recovery EEG Study
  ClinicalTrials.gov Identifier: NCT00483873 - Not yet recruiting
  Cardiac Arrest; Arrhythmia
  
• Cardiac Arrhythmia Pilot Study (CAPS)
  ClinicalTrials.gov Identifier: NCT00000504 - Completed
  Arrhythmia; Cardiovascular Diseases; Heart Diseases; Ventricular Arrhythmia
  
• Cardiac Arrhythmia Suppression Trial (CAST)
  ClinicalTrials.gov Identifier: NCT00000526 - Completed
  Cardiovascular Diseases; Coronary Disease; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; ...
  
• Cardiac Arrhythmias and the Perception of Symptoms
  ClinicalTrials.gov Identifier: NCT00005688 - Completed
  Cardiovascular Diseases; Heart Diseases; Arrhythmia
  
• Cardiac Autonomic Control in Children of HIV Positive Mothers
  ClinicalTrials.gov Identifier: NCT00005353 - Completed
  Acquired Immunodeficiency Syndrome; Arrhythmia; Heart Diseases; HIV Infections
  
• Cardiac Autonomic Functions During Head-Out Immersion and During Head Down Tilt
  ClinicalTrials.gov Identifier: NCT00515645 - Not yet recruiting
  Healthy
  
• Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates
  ClinicalTrials.gov Identifier: NCT00396838 - Recruiting
  Pain
  
• Cardiac Computarized Tomography in Infective Endocarditis
  ClinicalTrials.gov Identifier: NCT00550823 - Not yet recruiting
  Infective Endocarditis
  
• Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests
  ClinicalTrials.gov Identifier: NCT00541203 - Recruiting
  Coronary Disease